Drug · DIN 02212307
CEFTIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 28, 2022; first marketed September 13, 1999.
- Drug Identification Number (DIN)
- 02212307
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Granules For Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Cefuroxime J01DC02
- Class
- Human
- Record last updated
- October 21, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CEFUROXIME (CEFUROXIME AXETIL) | 125 MG | 5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 28, 2022: NOC 29345New Drug Submission (NDS) · Administrative: Change in Product Ownership
- June 22, 2001: NOC 2123New Drug Submission (NDS) · Change in manufacturer name
- February 26, 1996: NOC 4305New Drug Submission (NDS)